NASDAQ · Analyst Forecast

Evogene Ltd. (EVGN) Stock Forecast & Price Target

$0.34 NASDAQ: EVGN Market Cap $2.93M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Evogene Ltd. (EVGN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Evogene Ltd., analysts forecast revenue rising from $3.92M in 2025 to $14.15M in 2030; the average estimate for 2030 earnings per share is −$0.25; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$0.34
Consensus targetThe average of the price targets analysts have published.$2.15
Median targetThe middle target, less affected by a single outlier.$2.15
Highest targetThe most optimistic published target.$2.15
Lowest targetThe most pessimistic published target.$2.15
Difference from priceHow far the consensus target sits from today’s price.+532.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$3.92M$3.92M$3.92M1
2026$1.44M$1.44M$1.44M1
2027$2.60M$2.60M$2.60M1
2028$4.95M$4.95M$4.95M1
2029$8.30M$8.30M$8.30M1
2030$14.15M$14.15M$14.15M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.62−$0.62−$0.621
2026−$1.10−$1.10−$1.101
2027−$0.60−$0.60−$0.601
2028−$0.45−$0.45−$0.451
2029−$0.35−$0.35−$0.351
2030−$0.25−$0.25−$0.251

Evogene Ltd. (EVGN) forecast — frequently asked questions

What is the analyst price target for Evogene Ltd.?

Analysts covering Evogene Ltd. (EVGN) have a consensus price target of $2.15, 532.4% above the current price of $0.34. Published targets range from $2.15 to $2.15. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Evogene Ltd.'s earnings?

The average analyst estimate for Evogene Ltd. (EVGN) earnings per share in 2030 is -0.25, with individual estimates between -0.25 and -0.25.

How much revenue is Evogene Ltd. expected to make?

Analysts forecast Evogene Ltd. (EVGN) revenue of $14.15M in 2030, based on 1 published estimates.

How many analysts cover EVGN?

1 analyst contribute estimates for Evogene Ltd. (EVGN). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.